The splicing factor CELF2 suppresses RNA ligands sensed by RIG-I-like receptor
The splicing factor CELF2 suppresses RNA ligands sensed by RIG-I-like receptor
批准号:
10654469
负责人:
Ram Savan
金额:
$26.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-02-01 至 2025-01-31
关键词:
7SL RNAADAR1Alternative SplicingAutoimmunityBiogenesisCellsDNADefectDevelopmentDiseaseFailureFamily memberGenerationsGenesGenetic TranscriptionGoalsImmuneImmune signalingInfectionInnate Immune ResponseInterferon ActivationInterferon SuppressionInterferon Type IInterferonsLigandsMediatingMessenger RNANatural ImmunityNucleic AcidsPathogen detectionPathologyPathway interactionsPhenotypePlayPost-Transcriptional RegulationProteinsPseudogenesRNARNA EditingRNA SplicingRNA-Binding ProteinsReceptor ActivationRegulationReportingRoleSignal Recognition ParticleSignal TransductionTestingTissuesToll-like receptorsViralVirus DiseasesWorkadaptive immune responseimmune RNAmonocytenew therapeutic targetnovelpathogenic virusprogramsreceptorresponsesensorviral RNAviral detection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The goal of this proposal is to investigate a novel role of CELF2 in suppressing interferon responses to self-
RNA ligands. While interferons (IFN) induced by non-self-viral RNA activate an antiviral program to restrict viral
pathogens, their aberrant expression can cause tissue damage leading to autoimmunity. Although the toll-like
receptors and RIG-I-like receptors normally sense non-self RNA, these sensors are also activated by self-RNA
under certain conditions. Recognition of self-RNA can be a consequence of a failure of the suppression of the
self-RNA ligands. RNA editing by ADAR1 is one pathway used to suppress self-RNA ligands, but it is
conceivable that there are many other mechanisms that suppress endogenous immunostimulatory RNA
ligands. We made a surprising observation that the loss of splicing factor CELF2 induced a robust induction of
type I IFN and IFN-stimulated genes. Splicing factors are required for mRNA processing and post-
transcriptional regulation, however the effect of aberrant and alternative splicing on IFN responses is
understudied. We found that IFN induced during CELF2 depletion is dependent on RIG-I-like receptors. In this
proposal, we will identify the mechanisms of CELF2-mediated suppression of IFN activation. CELF2 has not
been previously implicated in suppressing immunostimulatory self-RNA ligands. This study will describe a
novel role for CELF2 in innate immune signaling, but also study the effect of perturbation of mRNA splicing on
innate immunity. This study has the potential to uncover mechanisms of the biogenesis of endogenous RNA
that activates the RLR pathway. These findings could have a significant impact on understanding IFN-induced
immune pathologies and identify new therapeutic targets in autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prenylation in antiviral immunity
-
批准号:10647533
-
项目类别:
-
资助金额:$64.66万
-
财政年份:2023
-
负责人:Ram Savan
-
依托单位:
Regulation of cardiomyocyte inflammation during viral infection
-
批准号:10244888
-
项目类别:
-
资助金额:$22.39万
-
财政年份:2020
-
负责人:Ram Savan
-
依托单位:
Regulation of cardiomyocyte inflammation during viral infection
-
批准号:9894164
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2020
-
负责人:Ram Savan
-
依托单位:
Translational Reprogramming by Regulatory T Cells
-
批准号:9765776
-
项目类别:
-
资助金额:$27.29万
-
财政年份:2019
-
负责人:Ram Savan
-
依托单位:
Functional insights into the IRF5 genetic variants marking SLE risk.
-
批准号:9116776
-
项目类别:
-
资助金额:$19.72万
-
财政年份:2015
-
负责人:Ram Savan
-
依托单位:
Functional insights into the IRF5 genetic variants marking SLE risk.
-
批准号:8968765
-
项目类别:
-
资助金额:$24.39万
-
财政年份:2015
-
负责人:Ram Savan
-
依托单位:
Novel regulatory mechanisms control IFNL3 expression during HCV infection
-
批准号:8990447
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2014
-
负责人:Ram Savan
-
依托单位:
Novel regulatory mechanisms control IFNL3 expression during HCV infection
-
批准号:8611757
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2014
-
负责人:Ram Savan
-
依托单位:
Novel regulatory mechanisms control IFNL3 expression during HCV infection
-
批准号:9273703
-
项目类别:
-
资助金额:$3.94万
-
财政年份:2014
-
负责人:Ram Savan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ADAR1抑制Z-DNA累积激活cGAS-STING信号通路并诱导中性粒细胞产生胞外诱捕网引起鼻咽癌放疗抵抗的机制
-
批准号:2025JJ50711
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王芙艳
-
依托单位:
诱导型ADAR1通过DNA-RNA杂合体堆积持续启动滞育样重编程介导舌鳞癌细胞休眠的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:李静远
-
依托单位:
ADAR1通过miR-181a-5p-ESM1信号调控母胎界面血管重铸的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:陈慧
-
依托单位:
肿瘤相关巨噬细胞诱发ADAR1介导的A-to-I编辑调控pri-miRNA的成熟在骨肉瘤侵袭转移中的作用及机制研究
-
批准号:82373051
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:鲍兴
-
依托单位:
ADAR1/MDA5介导的RNA调控在丹酚酸A抑制炎症微血管损伤改善糖尿病视网膜病变中的作用机制研究
-
批准号:82374110
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:张玲
-
依托单位:
ADAR1通过调控核糖体生物合成促进HER2阳性乳腺癌耐药的机制研究
-
批准号:82373357
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:迟亚云
-
依托单位:
高脂诱导Smad4蛋白调控ADAR1抑制HBV复制的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
m6A去甲基化酶ALKBH5调节RNA碱基编辑蛋白ADAR1抑制银屑病Th17分化的分子机制
-
批准号:82303995
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王孝波
-
依托单位:
ADAR1通过编辑p120调控F-actin-YAP/TAZ机械转导通路促进非小细胞肺癌生长和转移的机制研究
-
批准号:82303488
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:郑利军
-
依托单位:
ADAR1调控CDR1as-AP2M1通路抑制低级别胶质瘤相关性癫痫发生的机制研究
-
批准号:2023JJ30919
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:龙小艳
-
依托单位: